Review · Journal · 2026

Effectiveness and safety of ravulizumab in anti-acetylcholine receptor antibody-positive (AChR-Ab+) generalized myasthenia gravis: a systematic review and meta-analysis

Immunologic Research

Citations: 0from other works
Field-weighted impact: 0.001.00 is the world average for its field and year
Among its field: 21st percentileby citations, against works of its field and year
Authors: 8from 6 institutions

Authors

8 authors across 6 institutions in 3 countries